
  
    
      
        Background_NNP
        The_DT advent_NN of_IN the_DT polymerase_NN chain_NN reaction_NN (_( PCR_NNP )_) played_VBD
        an_DT important_JJ role_NN in_IN revolutionizing_VBG research_NN in_IN the_DT field_NN
        of_IN molecular_JJ biology_NN [_NN 1_CD ]_NN ._. A_DT recent_JJ adaptation_NN of_IN this_DT
        technology_NN ,_, known_VBN as_IN polymerase_NN colonies_NNS ,_, or_CC "_'' polonies_NNS "_'' ,_,
        holds_VBZ tremendous_JJ promise_NN as_RB well_RB ._. Polony_NNP technology_NN is_VBZ a_DT
        form_NN of_IN PCR_NNP in_IN which_WDT the_DT reaction_NN is_VBZ immobilized_JJ in_IN a_DT thin_JJ
        polyacrylamide_NN gel_NN attached_VBN to_TO a_DT microscope_NN slide_NN [_NN 2_CD 3_CD ]_NN ._.
        As_IN the_DT PCR_NNP proceeds_NNS ,_, the_DT PCR_NNP products_NNS diffuse_NN radially_RB
        within_IN the_DT gel_NN from_IN its_PRP$ immobilized_JJ template_NN (_( e_SYM ._. g_SYM ._. ,_, genomic_JJ
        DNA_NNP )_) ,_, giving_VBG rise_NN to_TO a_DT circular_JJ PCR_NNP product_NN ,_, or_CC polymerase_NN
        colony_NN ._. When_WRB the_DT gel_NN is_VBZ stained_JJ with_IN SybrGreen_NNP I_PRP and_CC
        scanned_JJ with_IN a_DT microarray_NN scanner_NN ,_, the_DT polymerase_NN colony_NN
        resembles_VBZ a_DT colony_NN on_IN an_DT agar_NN plate_NN ,_, hence_RB its_PRP$ name_NN ._.
        Herein_NNP ,_, we_PRP describe_VBP the_DT applications_NNS of_IN polony_NN technology_NN
        to_TO cancer_NN research_NN with_IN the_DT goal_NN of_IN screening_NN for_IN :_: 1_LS )_)
        mutations_NNS in_IN key_JJ tumor_NN suppressor_NN and_CC oncogenes_NNS ;_: as_RB well_RB as_IN
        2_LS )_) loss_NN of_IN heterozygosity_NN ._.
        One_CD of_IN the_DT hallmarks_NNS of_IN cancer_NN includes_VBZ the_DT accumulation_NN
        of_IN mutations_NNS in_IN key_JJ genes_NNS ,_, namely_RB DNA_NNP repair_NN genes_NNS [_NN 4_CD ]_NN ,_,
        tumor_NN suppressor_NN genes_NNS [_NN 5_CD 6_CD ]_NN ,_, and_CC proto-oncogenes_JJ [_NN 5_CD 6_CD
        ]_NN ,_, accompanied_VBN by_IN the_DT loss_NN of_IN the_DT wildtype_NN allele_NN ,_,
        resulting_VBG in_IN loss_NN of_IN heterozygosity_NN [_NN LOH_NNP ,_, see_VB reviews_NNS by_IN [_NN
        7_CD 8_CD 9_CD ]_NN ]_NN ._. Pancreatic_NNP cancer_NN ,_, which_WDT results_VBZ in_IN the_DT death_NN of_IN
        approximately_RB 30_CD ,_, 000_CD Americans_NNPS annually_RB and_CC is_VBZ the_DT fourth_JJ
        leading_VBG cause_NN of_IN cancer_NN mortalities_NNS in_IN the_DT United_NNP States_NNPS ,_,
        exhibits_VBZ this_DT hallmark_NN [_NN 10_CD ]_NN ._. For_IN example_NN ,_, in_IN pancreatic_JJ
        cancer_NN there_EX is_VBZ a_DT high_JJ incidence_NN of_IN mutations_NNS (_( >_NN 50_CD %_NN )_) in_IN
        the_DT tumor_NN suppressor_NN genes_NNS p_NN 16_CD ,_, p_NN 53_CD and_CC DPC_NNP 4_CD and_CC
        approximately_RB 90_CD %_NN of_IN cases_NNS coincide_VB with_IN a_DT mutation_NN in_IN the_DT
        oncogene_NN K-_NNP 
        ras_NNS 2_CD [_NN see_VB review_NN by_IN [_NN 11_CD ]_NN ]_NN ._.
        Furthermore_RB ,_, a_DT significant_JJ percentage_NN of_IN tumors_NNS harboring_VBG a_DT
        mutated_VBN copy_NN of_IN DPC_NNP 4_CD or_CC p_NN 53_CD also_RB lose_VB the_DT corresponding_JJ
        wildtype_NN allele_NN ,_, resulting_VBG in_IN LOH_NNP [_NN see_VB reviews_NNS by_IN [_NN 11_CD 12_CD ]_NN
        ]_NN ._.
        Of_IN particular_JJ importance_NN to_TO this_DT study_NN are_VBP the_DT genes_NNS p_NN 53_CD
        and_CC K-_NNP 
        ras_NNS 2_CD since_IN a_DT significant_JJ proportion_NN
        of_IN the_DT mutations_NNS are_VBP localized_VBN to_TO a_DT relatively_RB small_JJ number_NN
        of_IN mutational_NN hotspots_NNS [_NN 13_CD 14_CD 15_CD 16_CD ]_NN ._. In_IN this_DT paper_NN we_PRP
        introduce_VB a_DT screen_NN to_TO detect_VB the_DT presence_NN of_IN pancreatic_JJ
        cancer_NN by_IN looking_VBG for_IN somatic_JJ mutations_NNS in_IN p_NN 53_CD and_CC K-_NNP 
        ras_NNS 2_CD using_VBG polony_NN technology_NN to_TO
        microsequence_NN mutational_NN hotspots_NNS within_IN these_DT two_CD genes_NNS ._.
        In_IN addition_NN polonies_NNS are_VBP used_VBN to_TO diagnose_NN LOH_NNP in_IN these_DT same_JJ
        genes_NNS ._.
      
      
        Results_NNS
        Previous_JJ work_NN has_VBZ shown_VBN that_IN a_DT significant_JJ percentage_NN of_IN
        mutations_NNS in_IN p_NN 53_CD and_CC K-_NNP 
        ras_NNS 2_CD are_VBP localized_VBN to_TO mutational_NN
        hotspots_NNS ,_, namely_RB codons_NNS 175_CD ,_, 245_CD ,_, 248_CD ,_, 249_CD ,_, 273_CD ,_, and_CC 282_CD in_IN
        p_NN 53_CD and_CC codons_NNS 12_CD ,_, 13_CD ,_, and_CC 61_CD in_IN K-_NNP 
        ras_NNS 2_CD [_NN reviewed_VBN in_IN [_NN 14_CD 17_CD 18_CD ]_NN ]_NN ._.
        Each_DT of_IN these_DT mutational_NN hotspots_NNS was_VBD sequenced_JJ in_IN the_DT
        genomic_JJ DNA_NNP of_IN various_JJ pancreatic_JJ cell_NN lines_NNS using_VBG polony_NN
        technology_NN as_IN follows_VBZ ._. Initially_RB ,_, each_DT exon_NN bearing_VBG a_DT
        mutational_NN hotspot_NN was_VBD individually_RB PCR_NNP amplified_VBN in_IN a_DT
        polyacrylamide_NN gel_NN giving_VBG rise_NN to_TO one_CD polymerase_NN colony_NN ,_, or_CC
        polony_NN ,_, per_IN copy_NN of_IN genomic_JJ p_NN 53_CD or_CC K-_NNP 
        ras_NNS 2_CD DNA_NNP ._. The_DT non-acrydited_JJ strand_NN
        of_IN the_DT polony_NN was_VBD then_RB stripped_VBN away_RB after_IN formamide_NN
        treatment_NN and_CC electrophoresis_NNS ._. A_DT sequencing_VBG primer_NN was_VBD
        hybridized_JJ to_TO the_DT single-stranded_JJ copy_NN of_IN the_DT PCR-amplified_NNP
        p_NN 53_CD /_NN K-_NNP 
        ras_NNS 2_CD fragment_NN and_CC a_DT single_JJ base_NN
        extension_NN with_IN either_DT a_DT Cy-_NNP 3_CD or_CC Cy-_NNP 5_CD labeled_VBN dNTP_NN was_VBD
        performed_VBN prior_RB to_TO scanning_VBG on_IN a_DT microarray_NN scanner_NN ._. The_DT
        process_NN of_IN formamide_NN denaturation_NN ,_, hybridization_NN ,_, and_CC
        extension_NN was_VBD repeated_VBN 3_CD additional_JJ times_NNS in_IN order_NN to_TO
        perform_VB an_DT extension_NN with_IN each_DT of_IN the_DT four_CD dNTPs_NNS and_CC
        completely_RB sequence_NN each_DT position_NN ._.
        When_WRB all_PDT the_DT mutational_NN hotspots_NNS were_VBD sequenced_JJ in_IN the_DT
        Panc-_NNP 1_CD cell_NN line_NN (_( results_NNS of_IN sequencing_VBG in_IN Table_NNP 3_LS )_) ,_, it_PRP was_VBD
        determined_VBN that_IN K-_NNP 
        ras_NNS 2_CD was_VBD heterozygous_JJ (_( i_NNP ._. e_SYM ._. one_CD
        mutant_JJ and_CC one_CD wild_JJ type_NN allele_NN )_) at_IN the_DT second_JJ position_NN of_IN
        codon_NN 12_CD (_( Figure_NN 1_LS )_) and_CC p_NN 53_CD harbored_JJ a_DT mutation_NN at_IN the_DT
        second_JJ position_NN of_IN codon_NN 273_CD (_( Figure_NN 2_LS )_) ._. In_IN addition_NN to_TO the_DT
        cell_NN line_NN Panc-_NNP 1_CD ,_, K-_NNP 
        ras_NNS 2_CD mutations_NNS in_IN the_DT second_JJ
        position_NN of_IN codon_NN 12_CD were_VBD also_RB shown_VBN to_TO be_VB present_JJ in_IN the_DT
        cell_NN lines_NNS AsPC-_NNP 1_CD (_( G_NNP →_NN A_DT ;_: data_NN not_RB shown_VBN )_) and_CC CAPAN-_NNP 1_CD (_( G_NNP →_NN
        T_NN ;_: data_NNS not_RB shown_VBN )_) ._. These_DT results_NNS are_VBP in_IN agreement_NN with_IN
        previously_RB published_VBN data_NNS concerning_VBG the_DT genotype_NN of_IN these_DT
        cell_NN lines_NNS [_NN 19_CD 20_CD 21_CD ]_NN ._.
        One_CD hallmark_NN of_IN cancer_NN that_WDT can_MD be_VB readily_RB observed_VBN
        using_VBG polonies_NNS is_VBZ loss_NN of_IN heterozygosity_NN (_( LOH_NNP )_) ._. Polony_NNP
        technology_NN provides_VBZ this_DT capability_NN due_JJ to_TO its_PRP$ "_'' digital_JJ "_''
        nature_NN ,_, where_WRB one_CD DNA_NNP molecule_NN gives_VBZ rise_NN to_TO one_CD polony_NN ._. As_IN
        a_DT result_NN ,_, polonies_NNS can_MD be_VB used_VBN to_TO detect_VB changes_NNS in_IN gene_NN
        copy_NN number_NN that_WDT arise_VBP due_JJ to_TO either_CC deletions_NNS or_CC
        multiplications_NNS ._. For_IN example_NN ,_, previous_JJ studies_NNS have_VBP shown_VBN
        that_IN Panc-_NNP 1_CD has_VBZ two_CD copies_NNS of_IN K-_NNP 
        ras_NNS 2_CD ,_, but_CC only_RB one_CD copy_NN of_IN p_NN 53_CD ,_, due_JJ
        to_TO LOH_NNP [_NN 20_CD ]_NN ._. When_WRB equivalent_NN quantities_NNS of_IN Panc-_NNP 1_CD
        genomic_JJ DNA_NNP were_VBD polony_NN amplified_VBN ,_, there_EX were_VBD approximately_RB
        twice_RB as_IN many_JJ K-_NNP 
        ras_NNS 2_CD polonies_NNS as_IN there_EX were_VBD p_NN 53_CD
        polonies_NNS (_( Figure_NN 3_LS )_) ._. These_DT results_NNS ,_, taken_VBN in_IN conjunction_NN
        with_IN the_DT 
        in_IN situ_NN genotyping_VBG shown_VBN previously_RB
        in_IN Figures_NNS 2_CD and_CC 3_CD ,_, clearly_RB demonstrate_VB the_DT ability_NN of_IN
        polonies_NNS to_TO detect_VB LOH_NNP ._. It_PRP should_MD be_VB noted_VBN that_DT polony_NN
        amplification_NN of_IN genomic_JJ DNA_NNP from_IN strains_NNS with_IN equal_JJ p_NN 53_CD
        and_CC K-_NNP 
        ras_NNS 2_CD copy_NN numbers_NNS ,_, such_JJ as_IN CAPAN-_NNP 1_CD ,_,
        yielded_VBD equivalent_NN numbers_NNS of_IN p_NN 53_CD and_CC K-_NNP 
        RAS_NNP 2_CD polonies_NNS (_( data_NNS not_RB shown_VBN )_) ._. This_DT
        eliminates_VBZ the_DT role_NN of_IN primer_NN bias_NN contributing_VBG to_TO the_DT
        distinct_JJ number_NN of_IN p_NN 53_CD and_CC K-_NNP 
        ras_NNS 2_CD polonies_NNS amplified_VBN in_IN Panc-_NNP 1_CD
        genomic_JJ DNA_NNP ._.
      
      
        Discussion_NNP
        We_PRP have_VBP shown_VBN that_DT polony_NN technology_NN is_VBZ an_DT improved_VBN
        method_NN to_TO study_VB ,_, and_CC potentially_RB diagnosis_NN ,_, cancer_NN [_NN 22_CD ]_NN ._.
        Specifically_RB ,_, polony_NN technology_NN was_VBD successfully_RB applied_VBN to_TO
        both_DT detect_VB intragenic_JJ mutations_NNS in_IN well-defined_JJ mutational_NN
        hotspots_NNS in_IN key_JJ cancer_NN genes_NNS as_RB well_RB as_IN determine_VB if_IN loss_NN
        of_IN heterozygosity_NN of_IN these_DT same_JJ genes_NNS had_VBD occurred_VBN ._. For_IN
        example_NN ,_, Panc-_NNP 1_CD was_VBD determined_VBN to_TO possess_VB only_RB one_CD copy_NN of_IN
        p_NN 53_CD ,_, which_WDT possessed_VBD an_DT intragenic_JJ mutation_NN in_IN codon_NN 273_CD ,_,
        and_CC two_CD copies_NNS of_IN K-_NNP 
        ras_NNS 2_CD ,_, one_CD wildtype_NN and_CC one_CD with_IN an_DT
        intragenic_JJ mutation_NN in_IN codon_NN 12_CD ._. These_DT results_NNS are_VBP
        consistent_JJ with_IN findings_NNS from_IN previous_JJ work_NN [_NN 20_CD 21_CD ]_NN ._.
        The_DT approach_NN described_VBD herein_NN was_VBD applied_VBN to_TO a_DT clonal_NN
        cell_NN line_NN ._. However_RB ,_, this_DT approach_NN could_MD be_VB used_VBN to_TO detect_VB
        rare_JJ somatic_JJ mutations_NNS and_CC to_TO diagnosis_NN cancer_NN with_IN genomic_JJ
        DNA_NNP collected_VBD from_IN patient_NN samples_NNS or_CC biopsies_NNS [_NN 23_CD 24_CD 25_CD
        26_CD 27_CD ]_NN in_IN a_DT manner_NN similar_JJ to_TO Digital_NNP PCR_NNP developed_VBN by_IN
        Vogelstein_NNP and_CC Kinzler_NNP [_NN 22_CD ]_NN ._. In_IN the_DT case_NN of_IN analyzing_VBG
        pancreatic_JJ juice_NN for_IN p_NN 53_CD and_CC K-_NNP 
        ras_NNS 2_CD mutations_NNS ,_, it_PRP seems_VBZ likely_JJ that_IN
        only_RB a_DT small_JJ percentage_NN of_IN DNA_NNP harbors_NNS mutant_JJ DNA_NNP ._. However_RB ,_,
        polonies_NNS seem_VBP well_RB suited_VBN for_IN this_DT type_NN of_IN analysis_NN since_IN
        several_JJ hundred_CD to_TO several_JJ million_CD [_NN 2_CD ]_NN polonies_NNS for_IN a_DT
        particular_JJ gene_NN can_MD be_VB analyzed_VBN on_IN a_DT single_JJ slide_NN ,_, thereby_RB
        increasing_VBG the_DT likelihood_NN of_IN detecting_VBG a_DT rare_JJ event_NN [_NN 22_CD ]_NN
        ._. Additionally_RB ,_, the_DT frequency_NN of_IN mutations_NNS can_MD be_VB readily_RB
        determined_VBN using_VBG this_DT approach_NN due_JJ to_TO the_DT "_'' digital_JJ "_'' nature_NN
        of_IN polonies_NNS ._.
        Finally_RB ,_, it_PRP should_MD be_VB noted_VBN that_IN this_DT approach_NN is_VBZ not_RB
        without_IN limitations_NNS ._. For_IN example_NN ,_, sequencing_VBG each_DT
        mutational_NN hotspot_NN is_VBZ laborious_JJ and_CC detecting_VBG mutations_NNS
        outside_IN the_DT hotspots_NNS is_VBZ not_RB feasible_JJ ._. Adherence_NNP to_TO
        mutational_NN hotspots_NNS was_VBD directly_RB responsible_JJ for_IN the_DT
        inability_NN to_TO detect_VB the_DT p_NN 53_CD mutations_NNS in_IN the_DT CAPAN_NNP and_CC
        AsPc-_NNP 1_CD cell_NN lines_NNS [_NN 19_CD 21_CD ]_NN ._. The_DT best_JJS approach_NN for_IN
        detecting_VBG mutations_NNS outside_IN the_DT hotspots_NNS will_MD involve_VB
        direct_JJ sequencing_VBG of_IN the_DT polony_NN PCR_NNP products_NNS [_NN 2_CD 13_CD 14_CD ]_NN
        ._.
      
      
        Conclusions_NNP
        We_PRP have_VBP shown_VBN that_DT polony_NN technology_NN is_VBZ an_DT improved_VBN
        method_NN to_TO study_VB ,_, and_CC potentially_RB diagnosis_NN ,_, cancer_NN [_NN 22_CD ]_NN ._.
        Specifically_RB ,_, polony_NN technology_NN was_VBD successfully_RB applied_VBN to_TO
        both_DT detect_VB intragenic_JJ mutations_NNS in_IN well-defined_JJ mutational_NN
        hotspots_NNS in_IN key_JJ cancer_NN genes_NNS as_RB well_RB as_IN determine_VB if_IN loss_NN
        of_IN heterozygosity_NN of_IN these_DT same_JJ genes_NNS had_VBD occurred_VBN ._. These_DT
        results_NNS are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ work_NN [_NN
        20_CD 21_CD ]_NN ._.
      
      
        Methods_NNP
        
          Preparation_NNP of_IN Pancreatic_NNP Cell_NNP Line_NNP Genomic_NNP
          DNA_NNP
          The_DT pancreatic_JJ cell_NN lines_NNS AsPc-_NNP 1_CD ,_, CAPAN-_NNP 1_CD and_CC Panc-_NNP 1_CD
          were_VBD purchased_VBN from_IN the_DT American_NNP Type_NNP Culture_NNP Collection_NNP
          (_( Manassas_NNP ,_, VA_NNP )_) and_CC were_VBD grown_VBN according_VBG to_TO the_DT
          manufacturer_NN 's_POS instructions_NNS [_NN 28_CD 29_CD 30_CD ]_NN ._. Genomic_NNP DNA_NNP
          was_VBD harvested_VBN from_IN these_DT cells_NNS using_VBG a_DT Qiagen_NNP (_( Alameda_NNP ,_,
          CA_NNP )_) Blood_NNP and_CC Cell_NNP Culture_NNP DNA_NNP Midi_NNP Kit_NNP ._.
        
        
          Polony_NNP gels_NNS
          Polony_NNP gels_NNS for_IN genotyping_VBG mutational_NN hotspots_NNS were_VBD
          cast_VBN on_IN Teflon-printed_NNP microscope_NN slides_NNS as_IN described_VBN by_IN
          Mitra_NNP et_CC al_NN [_NN 3_CD ]_NN ._. The_DT Teflon-printed_NNP ,_, 24_CD ._. 4_LS ×_NN 16_CD ._. 7_CD mm_NN
          oval_NN slides_NNS (_( Grace_NNP Bio-_NNP Labs_NNPS ,_, Bend_NNP ,_, OR_NNP )_) were_VBD treated_VBN with_IN
          Bind_NNP Silane_NNP (_( Amersham_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) in_IN accordance_NN with_IN
          the_DT manufacture_NN 's_POS instructions_NNS ._. The_DT slides_NNS were_VBD stored_VBN in_IN
          a_DT desiccator_NN ._. To_TO cast_VB the_DT polyacrylamide_NN gels_NNS used_VBN for_IN
          the_DT immobilized_JJ PCR_NNP reaction_NN ,_, a_DT master_NN mix_NN was_VBD first_RB made_VBN
          for_IN 12_CD polony_NN gels_NNS (_( 131_CD ._. 0_CD μL_NN of_IN filter-sterilized_JJ doubly_RB
          deionized_JJ water_NN ,_, 25_CD ._. 5_LS μL_NN of_IN 10_CD X_NNP JumpStart_NNP Taq_NNP Polymerase_NNP
          Reaction_NNP Buffer_NNP (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) ,_, 2_CD ._. 55_CD μL_NN of_IN dNTP_NN
          (_( 20_CD mM_NN each_DT )_) ,_, 1_CD ._. 5_CD μL_NN of_IN 30_CD %_NN BSA_NNP (_( Sigma_NNP )_) ,_, 2_CD ._. 55_CD μL_NN 10_CD %_NN
          Tween_NNP 20_CD ,_, and_CC 56_CD ._. 16_CD μL_NN of_IN degassed_JJ ,_, filter-sterilized_JJ
          acrylamide_NN )_) ._. For_IN each_DT position_NN within_IN a_DT mutational_NN
          hotspot_NN to_TO be_VB genotyped_JJ ,_, 20_CD μL_NN of_IN master_NN mix_NN was_VBD combined_VBN
          with_IN 1_CD μL_NN of_IN genomic_JJ DNA_NNP as_RB well_RB as_IN 0_CD ._. 23_CD μL_NN of_IN each_DT the_DT
          forward_RB and_CC reverse_VB primers_NNS (_( 50_CD μM_NN each_DT ;_: see_VB Table_NNP 1_LS )_)
          designed_VBN to_TO polony_NN amplify_VB the_DT portion_NN of_IN the_DT exon_NN
          bearing_VBG the_DT mutational_NN hotspot_NN (_( s_VBZ )_) ._. Depending_VBG on_IN whether_IN
          the_DT sense_NN or_CC anti-sense_JJ strand_NN was_VBD to_TO be_VB sequenced_JJ ,_,
          either_CC the_DT forward_RB or_CC reverse_VB primer_NN was_VBD modified_VBN with_IN a_DT
          5_CD '_POS acrydite_NN to_TO covalently_RB attach_VB the_DT PCR_NNP product_NN to_TO the_DT
          acrylamide_NN matrix_NN (_( see_VB below_IN )_) ._. Immediately_RB prior_RB to_TO
          casting_VBG the_DT polony_NN gel_NN ,_, 1_CD ._. 38_CD μL_NN of_IN JumpStart_NNP Taq_NNP
          Polymerase_NNP (_( Sigma_NNP )_) ,_, 0_CD ._. 34_CD μL_NN of_IN 5_CD %_NN APS_NNP ,_, and_CC 0_CD ._. 34_CD μL_NN of_IN
          TEMED_NNP was_VBD added_VBN to_TO the_DT master_NN mix_NN /_NN primer_NN /_NN DNA_NNP solution_NN ._.
          The_DT gel_NN was_VBD polymerized_JJ for_IN 10_CD min_NN ,_, a_DT hybrid_NN well_RB cover_VB
          (_( Grace_NNP Bio-labs_NNP )_) was_VBD placed_VBN on_IN top_NN of_IN the_DT gel_NN and_CC light_JJ
          mineral_NN was_VBD pipeted_JJ into_IN the_DT hybrid_NN well_RB chamber_NN ._. The_DT
          slide_NN was_VBD placed_VBN in_IN a_DT placed_VBN in_IN an_DT 
          in_IN situ_NN PCR_NNP tower_NN (_( MJ_NNP Research_NNP ,_, MA_NNP )_)
          and_CC thermalcycled_JJ (_( 94_CD C_NNP for_IN 2_CD min_NN ;_: 39_CD cycles_NNS of_IN 94_CD C_NNP for_IN
          15_CD s_VBZ ,_, (_( T_NN 
          m_NN -_: 3_LS )_) C_NNP for_IN 30_CD s_VBZ and_CC 72_CD C_NNP for_IN 30_CD s_VBZ ;_:
          final_JJ extension_NN at_IN 72_CD C_NNP for_IN 2_CD min_NN )_) ._. (_( Note_VB :_: T_NN 
          m_NN is_VBZ the_DT melting_VBG temperature_NN of_IN the_DT
          PCR_NNP primer_NN with_IN the_DT lower_JJR melting_VBG temperature_NN in_IN a_DT given_VBN
          primer_NN pairing_VBG ._. )_)
          Upon_IN completion_NN of_IN the_DT PCR_NNP reaction_NN ,_, the_DT slide_NN was_VBD
          immersed_VBN in_IN clean_VB hexane_NN to_TO remove_VB oil_NN prior_RB to_TO staining_VBG
          in_IN 2_CD X_NNP Sybr_NNP Green_NNP (_( Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_) for_IN 15_CD
          minutes_NNS ._. The_DT slides_NNS was_VBD then_RB washed_VBN in_IN TBE_NNP and_CC scanned_JJ
          with_IN a_DT ScanArray_NNP 5000_CD microarray_NN scanner_NN (_( Perkin_NNP Elmer_NNP ,_,
          Wellesley_NNP ,_, MA_NNP )_) with_IN the_DT FITC_NNP laser_NN and_CC filter_NN set_VBN ._.
        
        
          Denaturation_NNP and_CC electrophoresis_NNS of_IN polony_NN
          gels_NNS
          Prior_RB to_TO genotyping_VBG ,_, the_DT double_RB stranded_VBN polonies_NNS were_VBD
          made_VBN single_JJ stranded_VBN by_IN stripping_VBG away_RB the_DT non-acrydited_JJ
          strand_NN in_IN a_DT two-step_JJ procedure_NN [_NN 3_CD ]_NN ._. The_DT polony_NN DNA_NNP was_VBD
          denatured_JJ by_IN incubation_NN in_IN a_DT formamide_NN buffer_NN (_( 1_CD x_SYM SSC_NNP ,_,
          70_CD %_NN formamide_NN ,_, 25_CD %_NN doubly_RB deionized-water_JJ )_) at_IN 70_CD C_NNP for_IN 15_CD
          min_NN ._. Immediately_RB following_VBG denaturation_NN ,_, the_DT gels_NNS were_VBD
          subjected_VBN to_TO electrophoresis_NNS (_( 42_CD %_NN urea_NN in_IN 0_CD ._. 5_CD x_SYM TBE_NNP )_) to_TO
          remove_VB the_DT non-acrydited_JJ strand_NN ._.
        
        
          Hybridization_NNP and_CC single_JJ base_NN extension_NN
          After_IN electrophoresis_NNS ,_, the_DT polony_NN slides_NNS were_VBD washed_VBN
          4_CD ×_NN in_IN wash_NN 1_CD E_NNP (_( 0_CD ._. 1_LS M_NNP Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, 20_CD mM_NN EDTA_NNP ,_, 0_CD ._. 5_CD M_NNP
          KCl_NNP )_) to_TO prepare_VB for_IN hybridization_NN of_IN the_DT sequencing_VBG
          primer_NN ._. 200_CD μL_NN of_IN annealing_VBG buffer_NN (_( 6_CD x_SYM SSPE_NNP ,_, 0_CD ._. 01_CD %_NN Triton_NNP
          X-_NNP 100_CD )_) containing_VBG 0_CD ._. 5_CD μM_NN primer_NN (_( Table_NNP 2_LS )_) was_VBD then_RB
          pipeted_JJ onto_IN the_DT gel_NN and_CC covered_VBN with_IN a_DT hybrid_NN well_RB
          chamber_NN ._. The_DT slide_NN was_VBD then_RB incubated_JJ for_IN 2_CD min_NN at_IN 94_CD C_NNP
          followed_VBN by_IN 20_CD min_NN at_IN (_( Tm-_NNP 3_LS )_) C_NNP to_TO facilitate_VB
          hybridization_NN ._.
          Genotyping_NNP of_IN mutational_NN hotspots_NNS was_VBD finally_RB
          accomplished_VBN by_IN performing_VBG single_JJ base_NN extensions_NNS of_IN the_DT
          hybridized_JJ sequencing_VBG primer_NN with_IN fluorescently_RB labeled_VBN
          deoxynucleotides_NNS ._. Following_VBG hybridization_NN ,_, the_DT gels_NNS were_VBD
          washed_VBN 2_CD ×_NN in_IN Wash_NNP 1_CD E_NNP and_CC then_RB equilibrated_JJ in_IN Klenow_NNP
          extension_NN buffer_NN (_( 50_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, 5_CD mM_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 01_CD %_NN Triton_NNP X-_NNP 100_CD )_) for_IN 1_CD minute_NN ._.
          For_IN each_DT sample_NN ,_, 50_CD μL_NN solution_NN containing_VBG approximately_RB
          5_CD units_NNS of_IN Klenow_NNP large_JJ fragment_NN (_( New_NNP England_NNP Biolabs_NNP ,_,
          Beverly_NNP ,_, MA_NNP )_) ,_, 3_CD μg_NN of_IN single_JJ stranded_VBN binding_JJ protein_NN (_( US_NNP
          Biochemicals_NNP ,_, Cleveland_NNP ,_, OH_NNP )_) ,_, and_CC 0_CD ._. 5_CD μM_NN Cy_NNP 3_CD -_: or_CC
          Cy_NNP 5_CD -_: labeled_VBN dATP_NN ,_, dCTP_NN ,_, dGTP_NN or_CC dUTP_NN (_( Perkin_NNP Elmer_NNP )_) was_VBD
          pipeted_JJ onto_IN the_DT gel_NN ._. The_DT single_JJ base_NN extension_NN was_VBD
          allowed_VBN to_TO proceed_VB for_IN 2_CD min_NN ._. The_DT gels_NNS were_VBD then_RB washed_VBN
          in_IN Wash_NNP 1_CD E_NNP to_TO reduce_VB background_NN fluorescence_NN and_CC scanned_JJ
          on_IN the_DT ScanArray_NNP 5000_CD with_IN the_DT appropriate_JJ lasers_NNS and_CC
          filters_NNS ._. The_DT process_NN of_IN formamide_NN denaturation_NN ,_,
          hybridization_NN ,_, extension_NN ,_, and_CC scanning_VBG was_VBD repeated_VBN 3_CD
          additional_JJ times_NNS for_IN each_DT primer_NN in_IN order_NN to_TO do_VB a_DT single_JJ
          base_NN extension_NN with_IN each_DT of_IN the_DT four_CD labeled_VBN
          nucleotides_NNS ._.
        
      
      
        Author_NN 's_POS contributions_NNS
        KD_NNP grew_VBD the_DT cell_NN lines_NNS used_VBN in_IN experiments_NNS ._. JB_NNP designed_VBD
        and_CC performed_VBD all_DT of_IN the_DT experiments_NNS in_IN this_DT manuscript_NN ._. JE_NNP
        and_CC EW_NNP conceived_VBD this_DT project_NN ._. All_DT authors_NNS read_VBP and_CC
        approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
